Searchable abstracts of presentations at key conferences in endocrinology

ea0029p553 | Diabetes | ICEECE2012

New fast and reversible leptin antagonist-induced mice model of metabolic syndrome and T2DM

Solomon G , Monsonego-Ornan E , Chapnik N , Smith E , Froy O , D'Alessio D , Gertler A

Obesity and its major consequence, type II diabetes mellitus (T2DM), is epidemic throughout Western society. T2DM accounts for 95% of the diabetes worldwide. One limitation to the development of new diabetes treatments has been a lack of effective animal models to use in research. There are no rodent models that recapitulate the pancreatic β-cell lesions of humans with T2DM. Moreover, animal models of obesity either require overfeeding which is expensive and takes weeks t...